The judging committee of the Prix Galien awards is comprised of internationally acclaimed scientists from the field of medicine, genetics, biotechnology, pharmacology, chemistry and molecular biology. The U.S. judging committee has been honoured by the presence of seven Nobel Prize winners. In our country, Greece, the members of the judging committee are the following outstanding personalities:

Honorary President

Dr. Aristeidis Α. Ν. Patrinos is Chief Scientist and Director for Research of the NOVIM Group. During 2012-2015 he directed research at the New York University (NYU) Center for Urban Science and Progress and was Distinguished Industry Professor of the Engineering School. During 2006-2012 he was President of Synthetic Genomics Inc. (SGI). Dr. Patrinos directed biological and environmental research at the U.S. Department of Energy (DOE, 1988-2006) including major contributions to the US Global Change Research Program and the Human Genome Project (HGP).
Dr. Patrinos serves on the Board of Directors of Tsakos Energy Navigation (TNP in NYSE) and of Liberty Biosecurity Inc. He is on advisory boards at the University of Pittsburgh Clinical and Translational Science Institute, Luna DNA Inc., and several DOE Labs. He consults for the Nuclear Threat Initiative, and Oak Ridge National Laboratory. At NYU he is now Visiting Scholar at the Center for Neural Science. During 2016, Dr. Patrinos was Senior Advisor to DOE Secretary of Energy Ernest Moniz working on joint efforts of DOE with the National Institutes of Health and the Department of Veterans Affairs.
Dr. Patrinos was a research scientist at Brookhaven National Laboratory (1980-1988) and Oak Ridge National Laboratory (1976-1980). During 1975-1976 he started his career at the University of Rochester as Assistant Professor of Engineering at the U of Rochester. He obtained his Ph.D. in Mechanical Engineering and Astronautical Sciences at Northwestern University in 1975 after receiving his Diploma in Mechanical and Electrical Engineering from the National Technical University of Athens.


George Chrousos is Professor and Chairman at the First Department of Pediatrics, Athens University Medical School and holds the seat of UNESCO Chair on Adolescent Healthcare. In 2011, he held the distinguished John Kluge Chair in Technology and Society. He has served as Chief of the Pediatric and Reproductive Endocrinology Branch of the National Institute of Child Health and Human Development and as Clinical Professor of Pediatrics, Physiology and Biophysics at Georgetown University. He has authored more then 650 scientific publications, his papers have been cited in more than 57,000 publications. He is one of the scientists with the highest citations in the world and is included in the ISI list of the highly cited in Clinical Medicine. Mr. Chrousos is a Master of the American College of Physicians and of the American College of Endocrinology and Fellow of the UK Royal College of Physicians. Among others, he is Doctor Honoris Causa of the Universities of Liege, Ancona and Patras. He has received many international awards and has been awarded the Bodossaki Aristeion Prize. He is an elected member of the Institute of Medicine of the US National Academy and of the Academy of Europe.


Stylianos E. Antonarakis is a professor of Genetic Medicine in the Medical School of Geneva University and President of the Institute of Genetics and Genomics iGE3 of Geneva. He has studied medicine in the University of Athens and genetics in the John Hopkins University School of Medicine. His academic contribution both in Johns Hopkins and Geneva Universities which extends to more than 30 years; includes the perception of the molecular base of monogenic disorders but also of complex genetic disorders, including beta thalassemia, haemophilia, trisomy 21, as well as the functional variability of the human genome. He has published extensively (more than 620 publications), is the editor of the current edition of the classical textbook “Genetics in Medicine” and is listed as one of the highly cited scientists according to ISI Institute (h-index 94). He was the president of the European Society of Human Genetics and President Elect of HUGO, 2013-2016.

Dr Efstathios Gonos graduated from the Department of Pharmacy, University of Athens, Greece in 1984, obtained his Ph.D. at the Department of Biochemistry, University of Glasgow, Britain in 1989 and a Docent in Biomedicine at the Orebro University, Medical School, Sweden in 2011. From 1989 to 1993 he worked as a Research Scientist at the Ludwig Institute for Cancer Research in London, Britain. Since 1994 he has been the group leader (and Director of Research since 2002) of the Department of ”Molecular and Cellular Aging” in NHRF/IBMCB that focuses on the genetic and environmental factors that are linked to human aging and longevity. He is funded by competitive grants awarded by the European Union, the Hellenic General Secretariat of Research & Technology as well as by private sources. He has published more than 120 research articles in eminent journals (> 4,000 citations), is author of 14 monographs and patents holder that have resulted in the development of novel anti-aging products. He has been invited to give lectures at more than 100 international Conferences (Gordon Conferences, UNESCO, FEBS, EMBO, IUBMB, EuroConference, European Parliament etc), has been co-organizing the EMBO/FEBS Spetses Summer Schools since 1999 and has organized, among others, the 2nd EuroConference on ”Biological Ageing”, the 12th International Association of Biomedical Gerontology Congress, the “Society of Free Radical Research Europe” annual Conference and the IUBMB Focused Meeting on “Molecular Aspects of Aging and Longevity”. Dr. Gonos has received fellowships from the University of Glasgow, the Ludwig Institute for Cancer Research and the Royal Society of G. Britain and was honored with the ”Hans Selye” award. He teaches in the post-graduate courses of Hellenic Universities and he is/has been co-supervisor of 15 Ph.D. theses. He has been a ”Senior expert” of E.U. in ”Human development and the aging process” and Deputy National Representative of Greece in E.U. in ”Genomics and Biotechnology for Health”. He is evaluator of several international organizations (European Union, UNESCO, Cancer Research U.K., Medical Research Council U.K., Austrian Science Fund, Italian Association for Cancer Research, Spanish Ministry of Health, Association for International Cancer Research etc), member of the Executive Committee of International Union of Biochemistry and Molecular Biology (IUBMB), past-member of the Advanced Course Committee of Federation of European Biochemical Societies (FEBS), past member of the Board of Directors of the ”Society of Free Radicals Research-Europe”, Editor-in-Chief of ”Mechanisms of Aging & Development” and Editorial Board member of ”Experimental Gerontology”, ”Free Radicals Research”, “IUBMB Life”, “Redox Biology”, “Ageing Research Reviews”, ”Aging Cell” (-2007), ”Biogerontology” (-2009) and ”Molecular Aspects of Medicine” (-2016).

Achilleas Gravanis, Professor of Pharmacology Medical School University of Crete. Researcher Institute of Molecular Biology & Biotechnology FORTH, Affiliated Research Professor Center of Drug Discovery Northeastern University Boston. Served as Member and Chairman of many research committees of the European Union, Member of the Fellowships Committee Federation European Biochemical Societies (FEBS), Member of the Council, Hellenic Quality Assurance Agency for Higher Education, Chairman of Bioscience Committee, Hellenic National Council of Research & Technology. Elected Member of the Scientific Board, Hellenic Foundation of Research & Innovation. Member of the Editorial Board and Reviewer of many international scientific journals. Co-founder of biotechnology spinoff Bionature Ltd, Collaborating Scientist, Emulate (Harvard spinoff). He has published more than 135 papers in PubMed (h-Index:44).

Nikos K. Moschonas is a professor of Medical Molecular Genetics and Director of the Laboratory of General Biology of the School of Medicine, University of Patras. He has studied biology and molecular genetics in the universities of Patras, Athens, Harvard and in the UK at the National Institute of Medical Research and Medical Research Council. He has served as professor in the Faculty of Biology in the University of Crete while at the same time he was an associate researcher at the Institute of Molecular Biology and Biotechnology (ΙΜΒΒ) FORTH-Hellas. In 2004, he was elected Professor in the Medical School of the University of Patras. He focuses on matters of molecular genetics with emphasis on the analysis of the molecular basis of genetic diseases and human functional genomics. His team participated in the international program for the analysis of the human genome (Human Genome Project). He has coordinated a plethora of programs and has published papers in international journals and 57 full original articles. He has prefaced four, and was the scientific editor in the Greek editions of three university textbooks of an international level. He was appointed member of various scientific committees of the European Union, Deputy Member of the National Council for Research and Technology and was the National Delegate EU Framework7 “Cooperation-Health” Programme Committee.

Kleomenis Barlos is a professor of Organic Chemistry in the University of Patras. He has developed pioneering methods in the synthesis of peptides and proteins using special polymers based on trityl resins, a fact that is internationally acclaimed as a major step in peptides’ and proteins’ synthesis to the large scale. More specifically, the resin also known as “Barlos Resin”, is considered the most important development internationally in the field of resins and was characterized as groundbreaking in the advancement of solid-phase synthesis of drugs and an extremely efficient tool in the discovery of new drugs. Already, Barlos Resin is used for the manufacture of more than 2,000 new drugs. In 1989, he founded the company CBL in Patras which specializes in producing materials with applications in the synthesis of peptides and proteins.


Charis S. Roussos (b. 1942 in Santorini, Member of the Academy of Athens since 2011). Charis Roussos graduated from the National University of Athens Medical School with Honours in 1966, specialized in Internal Medicine, and was an Intern and Resident in the University Department of Clinical Therapeutics from 1968 to 1972. From 1973 to 1982, he furthered his specialization in Internal and Pulmonary Medicine at Johns Hopkins University Hospital, Boston City Hospital (Tufts University, Harvard University, Boston University), Royal Victoria Hospital (McGill University) and Hôpital Universitaire Laennec (Paris). From 1982 until 1988, he was Professor and Director of the Critical Care Division (Royal Victoria Hospital, McGill University). From 1988 until 2009, he was Professor of Internal and Critical Care Medicine at the National University of Athens Medical School and Director of the University Critical Department at Evangelismos Hospital. He became Head of the Internal Medicine Division of the University of Athens and chair or member of several examination committees for diplomas in Internal Medicine, Pulmonary Medicine and Intensive Care Medicine, both in Greece and abroad. Charis Roussos received his Ph.D. from the University of Athens and McGill University with Honours (magna cum laude). He was awarded the titles of Scholar (1979) and Scientist (1984) by the Medical Research Council of Canada, Priv. Doz. of Internal Medicine at the University of Athens (1980), Professeur Associé at the University of Marseilles (1987) and Adjunct Professor at McGill University (1989-present). He is a member of the Royal College of Physicians of Canada (FRCP(C)), received the Jonathan Balloon Award by the Canadian Heart Association in 1981 and the Xanthopoulos-Pneumaticos Award for Excellence in Academic Teaching in 2008. He is a member of the Fleischner Society, which has 65 active members from around the globe, the American Society for Clinical Investigation, the Executive Committee of the European Society of Intensive Care Medicine, and became President of the European Respiratory Society. He has served as member of the Administrative Board of Evangelismos Hospital, of the Scientific Committee of the National Research Foundation, Head of the Committee of the Programme of Studies of Athens Medical School, Greek Representative to the World Health Organization (WHO) for tobacco-related issues, Chair or Member of Training Programmes of the Central Health Council, and Coordinator of the Committee for the Modernization of the Greek Healthcare Service. Charis Roussos is the author of numerous chapters in leading textbooks, such as Harrison’s Principles of Internal Medicine, Murray & Nadel’s Textbook of Respiratory Medicine, Principles of Critical Care Medicine (Hall, Schmidt & Wood), the Handbook of Physiology (Fishman, Mead & Macklem), as well as reviews in internationally renowned scientific journals, such as the New England Journal of Medicine). He has been a member of the Editorial Board of prestigious journals, (European Journal of Internal Medicine, Journal of Applied Physiology, Chest, and others). He is the Editor of 18 books (3 written in Greek, 5 written in English and 10 translated into Greek). He has written many editorials, and has been the main supervisor for over 50 Ph.D. dissertations, both in Greece and abroad. Many of his students have become Professors and/or Directors of Clinics in hospitals in Greece and abroad. Charis Roussos is the author of more than 500 papers, reviews and chapters written in English. He is one the most highly cited Greek scientists, and many of his studies have been characterized as seminal. E.J.M. Campbell, Professor of Pulmonary and Intensive Care Medicine at the Hammersmith Hospital, once stated that the research conducted by Charis Roussos was the most significant in its field for the 1980s. Ventilation distribution, respiratory muscle fatigue and chest wall mechanics constitute only a few of his research interests, while a number of experimental studies on the use of flavonoids for the treatment of infections and sepsis, new methods of cardiopulmonary resuscitation, and the role of non-myelinated nerve fibers of the diaphragm have been endorsed by the European Union. Charis Roussos is the founder and Chair of the Thorax Foundation, Vice-Chair of the Santorini Poorhouse, Chair of the K. & A. Roussos Charitable Foundation, coordinator in the reconstruction of the Santorini Hospital, in charge of smoking cessation programmes, and responsible for the funding and construction of the new ward in Evangelismos Hospital in Athens.